Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Redifferentiation therapy with retinoic acid in follicular thyroid cancerF Grünwald, E Pakos, H Bender, et al.
Clinical Nuclear Medicine|September 9, 1999
Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastasesH Palmedo, H Bender, C Dierke-Dzierzon, et al.
Kidney International|May 26, 2006
Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipientsU Pöge, T Gerhardt, B Stoffel-Wagner, et al.
Der Radiologe|November 2, 2004
[PET/CT imaging in head and neck tumors]R Rödel, H J Straehler-Pohl, H Palmedo, et al.
Anticancer Research|May 1, 1997
Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatmentF F Knapp, A L Beets, S Guhlke, et al.
Cancer Investigation|April 9, 2005
Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserveAlexander Matthies, M Reinhardt, H Palmedo, et al.
Aktuelle Urologie|May 31, 2006
[Technical limits of PET/CT with 18FDG in prostate cancer]D von Mallek, B Backhaus, S C Müller, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 31, 2000
Intraarterial HCC therapy with I-131-LipiodolJ H Risse, F Grünwald, W Kersjes, et al.
Nuklearmedizin. Nuclear Medicine|September 12, 2006
Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohortJ H Risse, C Rabe, D Pauleit, et al.
European Journal of Nuclear Medicine|February 7, 2001
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastasesH Palmedo, S Guhlke, H Bender, et al.
Pageof 5